Yingbin Fu

Dr. Yingbin Fu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
YFYingbin Fu
Yingbin Fu
ZZZhao Zhang
Zhao Zhang
KWKeith A. Webster
Keith A. Webster
YPYannis Mantas Paulus
Yannis Mantas Paulus
Despite extensive use of intravitreal anti-vascular endothelial growth factor (anti-VEGF) biologics for over a decade, neovascular age-related macular degeneration (nAMD) or choroidal neovascularization (CNV) continues to be a major cause of irreversible vision loss in developed countries. Many nAMD patients demonstrate persistent disease activity or experience declining responses over time despite anti-VEGF treatment. The underlying mechanisms of anti-VEGF resistance are poorly understood, and no effective treatment strategies are available to date. Here we review evidence from animal models and clinical studies that supports the roles of neovascular remodeling and arteriolar CNV formation in anti-VEGF resistance. Cholesterol dysregulation, inflammation, and ensuing macrophage activation are critically involved in arteriolar CNV formation and anti-VEGF resistance. Combination therapy by neutralizing VEGF and enhancing cholesterol removal from macrophages is a promising strategy to combat anti-VEGF resistance in CNV.

1 December 2017 in The American Journal of Pathology
Verified
Journal Article
Closed access
SKSandeep Kumar
Sandeep Kumar
HNHiroyuki Nakashizuka
Hiroyuki Nakashizuka
AJAlex Jones
Alex Jones
ALAlyssia Lambert
Alyssia Lambert
XZXuchen Zhao
Xuchen Zhao
YFYingbin Fu
Yingbin Fu

26 July 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TZTao Zhang
Tao Zhang
LCLi-Hui Cao
Li-Hui Cao
SKSandeep Kumar
Sandeep Kumar
NENduka O. Enemchukwu
Nduka O. Enemchukwu
NZNing Zhang
Ning Zhang
YFYingbin Fu
Yingbin Fu
It is a deeply engrained notion that the visual pigment rhodopsin signals light as a monomer, even though many G protein-coupled receptors are now known to exist and function as dimers. Nonetheless, recent studies (albeit all in vitro) have suggested that rhodopsin and its chromophore-free apoprotein, R-opsin, may indeed exist as a homodimer in rod disk membranes. Given the overwhelmingly strong historical context, the crucial remaining question, therefore, is whether pigment dimerization truly exists naturally and what function this dimerization may serve. We addressed this question in vivo with a unique mouse line (S-opsin+Lrat−/−) expressing, transgenically, short-wavelength–sensitive cone opsin (S-opsin) in rods and also lacking chromophore to exploit the fact that cone opsins, but not R-opsin, require chromophore for proper folding and trafficking to the photoreceptor’s outer segment. In R-opsin’s absence, S-opsin in these transgenic rods without chromophore was mislocalized; in R-opsin’s presence, however, S-opsin trafficked normally to the rod outer segment and produced functional S-pigment upon subsequent chromophore restoration. Introducing a competing R-opsin transmembrane helix H1 or helix H8 peptide, but not helix H4 or helix H5 peptide, into these transgenic rods caused mislocalization of R-opsin and S-opsin to the perinuclear endoplasmic reticulum. Importantly, a similar peptide-competition effect was observed even in WT rods. Our work provides convincing evidence for visual pigment dimerization in vivo under physiological conditions and for its role in pigment maturation and targeting. Our work raises new questions regarding a potential mechanistic role of dimerization in rhodopsin signaling. Significance Despite in vitro evidence, it remains unclear whether the rod visual pigment rhodopsin exists as dimers in vivo. With a unique mouse line that expresses the blue cone opsin transgenically in rods, we showed that, in the absence of chromophore, the transgenic cone opsin can mature and target to the outer segment if and only if rhodopsin is present to help it along (i.e., forming heterodimers in the endoplasmic reticulum). Furthermore, we have confirmed a key interaction domain for rhodopsin dimerization and show that, again in vivo, rhodopsin maturation and targeting to the outer segment becomes defective when dimerization is disrupted. This work provides in vivo evidence for rhodopsin existing as a dimer.

18 February 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
HXHui Xu
Hui Xu
NENduka Enemchukwu
Nduka Enemchukwu
XZXiaoyue Zhong
Xiaoyue Zhong
OZOlivia Zhang
Olivia Zhang
YFYingbin Fu
Yingbin Fu

13 August 2022 in Experimental Eye Research
Verified
Journal Article
Closed access
VNVan Phuc Nguyen
Van Phuc Nguyen
JHJessica Henry
Jessica Henry
JZJosh Zhe
Josh Zhe
QKQuynh Kieu
Quynh Kieu
WQWei Qian
Wei Qian
YPYannis Mantas Paulus
Yannis Mantas Paulus

23 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
HXHui Xu
Hui Xu
Nange JinNange Jin
Nange Jin
JCJen-Zen Chuang
Jen-Zen Chuang
ZZZhao Zhang
Zhao Zhang
XZXiaoyue Zhong
Xiaoyue Zhong
YFYingbin Fu
Yingbin Fu
Significance: The study of visual pigments (rhodopsin in rods and cone opsins in cones) in vision has a long and illustrious history. It is well established that rhodopsin is required for rod phototransduction, outer segment formation, and rod viability. It is not known if the same is true for the cones. By using the cone opsin–deficient mice, we made the surprising observation that cones survive for at least 12 mo without cone opsins, suggesting that cone opsins are dispensable for cone viability. Furthermore, cone opsin–deficient cones continue to mediate visual signaling by relaying the rod signal through rod–cone gap junctions. Our finding represents a major difference between the two types of photoreceptors in vertebrates: rods and cones.